Home Cart 0 Sign in  

[ CAS No. 1073160-26-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1073160-26-5
Chemical Structure| 1073160-26-5
Structure of 1073160-26-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1073160-26-5 ]

Related Doc. of [ 1073160-26-5 ]

Alternatived Products of [ 1073160-26-5 ]

Product Details of [ 1073160-26-5 ]

CAS No. :1073160-26-5 MDL No. :MFCD28144730
Formula : C20H22ClF3N8O3S Boiling Point : -
Linear Structure Formula :- InChI Key :RCHQNUQAHJNRBY-UHFFFAOYSA-N
M.W : 546.95 Pubchem ID :25117347
Synonyms :
PF 04554878 hydrochloride;VS-6063 hydrochloride;Defactinib hydrochloride

Calculated chemistry of [ 1073160-26-5 ]

Physicochemical Properties

Num. heavy atoms : 36
Num. arom. heavy atoms : 18
Fraction Csp3 : 0.25
Num. rotatable bonds : 10
Num. H-bond acceptors : 10.0
Num. H-bond donors : 3.0
Molar Refractivity : 129.09
TPSA : 150.48 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -8.05 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 2.23
Log Po/w (WLOGP) : 5.09
Log Po/w (MLOGP) : 0.75
Log Po/w (SILICOS-IT) : 0.94
Consensus Log Po/w : 1.8

Druglikeness

Lipinski : 2.0
Ghose : None
Veber : 1.0
Egan : 1.0
Muegge : 1.0
Bioavailability Score : 0.17

Water Solubility

Log S (ESOL) : -4.35
Solubility : 0.0247 mg/ml ; 0.0000451 mol/l
Class : Moderately soluble
Log S (Ali) : -5.03
Solubility : 0.00516 mg/ml ; 0.00000943 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -7.57
Solubility : 0.0000147 mg/ml ; 0.0000000269 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 3.78

Safety of [ 1073160-26-5 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338 UN#:
Hazard Statements:H302-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 1073160-26-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1073160-26-5 ]

[ 1073160-26-5 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 1073160-19-6 ]
  • N-(3-aminomethyl-pyrazin-2-yl)-N-methyl-methane sulfonamide acetate [ No CAS ]
  • [ 1073160-26-5 ]
YieldReaction ConditionsOperation in experiment
100% Stage #1: 4-((4-chloro-5-(trifluoromethyl)pyrimidin-2-yl)amino)-N-methylbenzamide; N-(3-aminomethyl-pyrazin-2-yl)-N-methyl-methane sulfonamide acetate With N-ethyl-N,N-diisopropylamine In 1,1-dichloroethane; <i>tert</i>-butyl alcohol at 88℃; for 1.5h; Stage #2: With hydrogenchloride In 1,4-dioxane at 20℃; for 1h; 15A Example 15A; Preparation of 4-(4-[(3-methanesulfonyl-methyl-amino)-pyrazin-2-ylmethyl]-amino}-5-(trifluoromethyl)-pyrimidin-2-ylamino)-N-methyl-benzamide hydrochloride salt (15A) Step 1. A suspension of B20 (26.3 mmol), B2 (28.9 mmol) and diisopropylethyl amine (105 mmol) was mixed in 1:1 DCE:tBuOH (80 mL) and heated to 88° C. in a sealed flask for 1.5 hour. The mixture turned green and a solid precipitated. The suspension was diluted with Et2O/EtOH (10:1) and filtered to obtain 10.1 g of a white solid (75%). 8 g of this product was slurried in 400 mL of MeOH and to the mixture was added 18 mL 4.0M HCl in dioxane. This was stirred at room temperature for 1 hour, then it was filtered to obtain 15A as an off-white solid HCl salt (quant yield). 1H NMR (400 MHz, DMSO-d6) δ ppm 2.75 (d, J=3.74 Hz, 3H), 3.18 (m, 6H), 5.01 (d, J=4.98 Hz, 2H), 7.52 (d, 2H), 7.67 (d, J=8.72 Hz, 2H), 7.98 (br. s., 1H), 8.29 (d, J=4.15 Hz, 1H), 8.42 (s, 1H), 8.59 (d, 1H), 8.68 (d, 1H), 10.38 (s, 1H). ESI-MS: 511.1 (MH+), 509.2 (M-H)-. FAK IC50: 0.00179 μM (Table 1, Example 318)
Same Skeleton Products
Historical Records